Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Akoya Biosciences Inc (AKYA)

Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 64,441
  • Shares Outstanding, K 49,954
  • Annual Sales, $ 81,670 K
  • Annual Income, $ -55,370 K
  • EBIT $ -39 M
  • EBITDA $ -31 M
  • 60-Month Beta 1.36
  • Price/Sales 0.83
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.94
  • Most Recent Earnings $-0.32 on 05/12/25
  • Next Earnings Date 08/04/25
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.27
  • Prior Year -0.27
  • Growth Rate Est. (year over year) +18.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0900 +18.35%
on 06/09/25
1.6400 -21.34%
on 07/07/25
+0.1300 (+11.21%)
since 06/06/25
3-Month
0.9310 +38.56%
on 05/15/25
1.6400 -21.34%
on 07/07/25
+0.1200 (+10.26%)
since 04/07/25
52-Week
0.9310 +38.56%
on 05/15/25
3.4200 -62.28%
on 01/10/25
-0.8000 (-38.28%)
since 07/05/24

Most Recent Stories

More News
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

/CNW/ -- Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is...

ONCY : 0.9921 (+1.16%)
ACLX : 69.56 (+1.62%)
TCRX : 1.0800 (-0.92%)
ONC.TO : 1.42 (+2.16%)
AKYA : 1.2900 (-5.15%)
QTRX : 7.63 (-0.91%)
Akoya: Q1 Earnings Snapshot

Akoya: Q1 Earnings Snapshot

AKYA : 1.2900 (-5.15%)
Akoya Biosciences Reports First Quarter 2025 Financial Results

AKYA : 1.2900 (-5.15%)
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

AKYA : 1.2900 (-5.15%)
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

AKYA : 1.2900 (-5.15%)
Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

AKYA : 1.2900 (-5.15%)
Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

AKYA : 1.2900 (-5.15%)
Akoya: Q4 Earnings Snapshot

Akoya: Q4 Earnings Snapshot

AKYA : 1.2900 (-5.15%)
Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

AKYA : 1.2900 (-5.15%)
QTRX : 7.63 (-0.91%)
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

AKYA : 1.2900 (-5.15%)

Business Summary

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM)...

See More

Key Turning Points

3rd Resistance Point 1.8733
2nd Resistance Point 1.7567
1st Resistance Point 1.5233
Last Price 1.2900
1st Support Level 1.1733
2nd Support Level 1.0567
3rd Support Level 0.8233

See More

52-Week High 3.4200
Fibonacci 61.8% 2.4692
Fibonacci 50% 2.1755
Fibonacci 38.2% 1.8818
Last Price 1.2900
52-Week Low 0.9310

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar